DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ shed 2.49% to $22.32 Monday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 2.64% to 18,350.19 and Dow Jones Industrial Average falling 1.48% to 43,191.24.
The stock's fall snapped a two-day winning streak.
Catalyst Pharmaceuticals Inc. closed 9.42% short of its 52-week high of $24.64, which the company achieved on January 30th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 1.37% to $167.28, Pfizer Inc. $(PFE)$ fell 0.68% to $26.25, and Abbott Laboratories $(ABT)$ rose 1.60% to $140.22.
Trading volume (1.5 M) eclipsed its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 3, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 03, 2025 17:23 ET (22:23 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.